Bio-Techne (TECH) Free Cash Flow (2009 - 2026)
Bio-Techne (TECH) posted quarterly Free Cash Flow of $77.6 million for Q1 2026, up 150.27% year-over-year from $31.0 million in Q1 2025, and up 1.42% quarter-over-quarter from $76.5 million in Q4 2025.
Analysis
Bio-Techne (TECH) Free Cash Flow (2009 - 2026) Analysis & Trends
Bio-Techne's Free Cash Flow history runs 18 years deep, the most recent figure standing at $77.6 million for Q1 2026.
- In Q1 2026, Free Cash Flow rose 150.27% year-over-year to $77.6 million; the TTM figure through Mar 2026 stood at $269.6 million (up 22.13% YoY), while the FY2025 annual figure was $256.6 million, up 8.66% from the prior year.
- Free Cash Flow for Q1 2026 stood at $77.6 million, up from $76.5 million in the prior quarter.
- The five-year high for Free Cash Flow was $93.3 million in Q2 2025, with the low at $22.2 million in Q3 2025.
- The 5-year median for Free Cash Flow is $58.3 million (2022), against an average of $60.7 million.
- The sharpest annual moves came in 2025 and 2026: Free Cash Flow sank 59.39% in 2025, then soared 150.27% in 2026.
- Bio-Techne's Free Cash Flow stood at $58.3 million in 2022, then advanced by 17.12% to $68.3 million in 2023, then increased by 13.59% to $77.5 million in 2024, then dropped by 1.34% to $76.5 million in 2025, then grew by 1.42% to $77.6 million in 2026.
- Business Quant data shows TECH's Free Cash Flow at $77.6 million in Q1 2026, $76.5 million in Q4 2025, and $22.2 million in Q3 2025.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Free Cash Flow (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 138.47 Bn | 130.62 Bn | 2.84 Bn | 1.01 Bn |
| 2 | Regeneron Pharmaceuticals | 85.18 Bn | 77.19 Bn | 3.93 Bn | 572.80 Mn |
| 3 | Argenx Se | 63.38 Bn | 58.19 Bn | 1.37 Bn | - |
| 4 | Moderna | 58.09 Bn | 52.95 Bn | 52.00 Mn | -563.00 Mn |
| 5 | Revolution Medicines | 44.33 Bn | 44.33 Bn | - | -389.61 Mn |
| 6 | BeOne Medicines | 40.02 Bn | 34.92 Bn | 1.53 Bn | 437.80 Mn |
| 7 | Alnylam Pharmaceuticals | 35.57 Bn | 32.27 Bn | 992.69 Mn | 292.04 Mn |
| 8 | Royalty Pharma | 28.45 Bn | 27.61 Bn | - | 477.44 Mn |
| 9 | Insmed | 27.48 Bn | 26.32 Bn | 358.27 Mn | -95.09 Mn |
| 10 | Bio-Techne | 11.29 Bn | 11.03 Bn | 211.39 Mn | 86.94 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 86.94 Mn |
| Mar 31, 2026 | 77.58 Mn |
| Dec 31, 2025 | 76.49 Mn |
| Sep 30, 2025 | 22.22 Mn |
| Jun 30, 2025 | 93.31 Mn |
| Mar 31, 2025 | 31.00 Mn |
| Dec 31, 2024 | 77.53 Mn |
| Sep 30, 2024 | 54.72 Mn |
| Jun 30, 2024 | 57.52 Mn |
| Mar 31, 2024 | 64.55 Mn |
| Dec 31, 2023 | 68.25 Mn |
| Sep 30, 2023 | 45.79 Mn |
| Jun 30, 2023 | 72.56 Mn |
| Mar 31, 2023 | 38.79 Mn |
| Dec 31, 2022 | 58.28 Mn |
| Sep 30, 2022 | 46.53 Mn |
| Jun 30, 2022 | 89.15 Mn |
| Mar 31, 2022 | 58.03 Mn |
| Dec 31, 2021 | 90.83 Mn |
| Sep 30, 2021 | 42.36 Mn |